138 Chapter 3 OR “plasma derived therapeutic proteins”[tw] OR “plasma derived therapeutics”[tw] OR “plasma derived therapies”[tw] OR “plasma derived drugs” [tw] OR ((“PDMP”[tw] OR “PDMPs”[tw]) AND “plasma”[tw]) OR “Plasma Products”[tw] OR “Plasma Product”[tw] OR ((“Pharmaceutical Preparations”[mesh] OR “Biological Products”[mesh] OR “Biopharmaceutics”[mesh]) AND (“Plasma”[mesh] OR “plasma”[ti])) OR “Immunoglobulins, Intravenous”[Mesh] OR “Intravenous Immunoglobulin”[tw] OR “Intravenous Immunoglobulins”[tw] OR “Intravenous IG”[tw] OR “IVIG”[tw] OR “IVIGs”[tw] OR “Intravenous Immune Globulin”[tw] OR “IV Immunoglobulins”[tw] OR “Flebogamma DIF”[tw] OR “Gamunex”[tw] OR “Globulin-N”[tw] OR “Globulin N”[tw] OR “Intraglobin”[tw] OR “Intraglobin F”[tw] OR “Gammagard”[tw] OR “Gamimune”[tw] OR “Gamimmune”[tw] OR “Modified Immune Globulin”[tw] OR “Privigen”[tw] OR “Sandoglobulin”[tw] OR “Venoglobulin”[tw] OR “Venoglobulin-I”[tw] OR “Venoglobulin I”[tw] OR “Iveegam”[tw] OR “Alphaglobin”[tw] OR “Endobulin”[tw] OR “Gamimune N”[tw] OR “Gamimmune N”[tw] OR “Gammonativ”[tw]))) NOT (“Animals”[mesh] NOT “Humans”[mesh]) AND (“2008/01/01”[PDAT] : “3000/12/31”[PDAT]) Exclusion criteria: • No animals • No studies before 2010 • No studies in a language other than English or Dutch • No studies regarding ‘on-label’ or ‘established’ indications with no reported changes (e.g. dosage) that would warrant impact on future demand • No full text available
RkJQdWJsaXNoZXIy MTk4NDMw